EE715 Faricimab Vs. Standard of Care in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Cost-Utility Analysis in Italy
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.980
https://www.valueinhealthjournal.com/article/S1098-3015(23)04110-4/fulltext
Title :
EE715 Faricimab Vs. Standard of Care in Patients with Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Cost-Utility Analysis in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04110-4&doi=10.1016/j.jval.2023.09.980
First page :
Section Title :
Open access? :
No
Section Order :
10474